Rx Update: Xtoro (Finafloxacin Otic Suspension)

Friday July 31, 2015
Xtoro by Alcon Laboratories, approved December 17, 2014, is a quinolone antimicrobial indicated for the treatment of acute otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus. Prolonged use of Xtoro may lead to overgrowth of nonsusceptible organisms. Allergic reactions may occur in patients with a history of hypersensitivity to finafloxacin, other quinolones, or any of the components in this medication. Cross-resistance has been observed between finafloxacin and other fluoroquinolones but not between finafloxacin and other classes of antibacterial agents. Patients should be advised that if a rash or allergic reaction occurs, they should discontinue the use of the product immediately and contact their physician.
 
Before administration of Xtoro, patients or caregivers should warm the bottle by holding it in their hands for 1 or 2 minutes to avoid dizziness that may result from the instillation of a cold solution. Xtoro is administered by instilling 4 drops in the affected ear(s) twice daily for 7 days. For patients requiring use of an ear wick, the initial dose can be doubled (to 8 drops), followed by 4 drops instilled into the affected ear twice daily for 7 days.
 
Dosage form and strength: 5 mL of finafloxacin otic suspension, 0.3%, in an 8-mL bottle. Xtoro is a Pregnancy Category C medication. The most common adverse reactions, occurring in 1% of patients, were ear pruritus and nausea.

Source: Xtoro prescribing information.


Current Issue

The Educated Patient

Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
Kristen Marjama, DNP, FNP-BC
Gluten proteins found in barley, rye, and wheat trigger systemic injury primarily to the small intestine, but they can also affect the joints, liver, skin, uterus, and other organs.
Kristen Marjama, DNP, FNP-BC
It is that time of year again, when health care providers see an increase in patient volume because no one has time to be sick.
Sara Marlow, MSN, RN, PHN, FNP-C
Sunburn is still a major health issue that can be prevented.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2018
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.